The Laboratory Information Tsunami
Are current LIS and LIMS prepared for the coming flood of personalized medicine data?
Read More
Search Results for: point-of-care
April 2017 Product Spotlight: Emerging Technologies, Part 2
This month’s issue features emerging technologies from such companies as Clinical Genomics, Hamilton Storage, and Symcel.
Read More
FDA Clears Alere Immunoassay Analyzer
The diagnostic system features objective results interpretation and connectivity capabilities, and can be used to evaluate lateral-flow immunoassays in a wide variety of formats.
Read More
BD Immunoassay Meets FDA’s New Performance Requirements for RIDTs
FDA has reclassified antigen-based rapid influenza virus antigen detection systems intended to detect influenza virus directly from clinical specimens from Class I devices into Class II devices subject to special controls.
Read More
Abbott Diagnostic Systems Score CE Mark
The clinical chemistry and immunoassay technologies allow for cost-effective volume growth in a footprint half the size of Abbott’s current diagnostics systems.
Read More